Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rua Bioscience Limited Share Issue/Capital Change 2025

Aug 14, 2025

66262_rns_2025-08-14_8cae8694-b492-4dc1-ae09-e2692188e6d2.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Capital Change Notice

==> picture [73 x 32] intentionally omitted <==

Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency NZ$
Section 2: Capital change details
Number issued/acquired/redeemed 4,666,667
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $0.03
Nature of the payment (for example, cash or otherconsideration) Cash
Amount paid up (if not in full) Paid in full
Percentage of total class of Financial Productsissued/acquired/redeemed/ (calculated on the number ofFinancial Products of the Class, excluding any Treasury Stock,in existence)1 2.00%
For an issue of Convertible Financial Products or Options, theprincipal terms of Conversion (for example the Conversionprice and Conversion date and the ranking of the FinancialProduct in relation to other Classes of Financial Product) or theOption (for example, the exercise price and exercise date) N/A
Reason for issue/acquisition/redemption and specific authorityfor issue/acquisition/redemption/ (the reason for change mustbe identified here) Placement of new ordinaryshares to fund short-termworking capital requirementsand authorised by a Boardresolution on 7th August 2025.
Total number of Financial Products of the Class after theissue/acquisition/redemption/Conversion (excluding TreasuryStock) and the total number of Financial Products of the Classheld as Treasury Stock after the issue/acquisition/redemption. 238,048,011 ordinary shares.
In the case of an acquisition of shares, whether those sharesare to be held as treasury stock N/A
Specific authority for the issue, acquisition, or redemption,including a reference to the rule pursuant to which the issue,acquisition, or redemption is made Placement of new ordinaryshares pursuant to Listing Rule4.5.1.
Terms or details of the issue, acquisition, or redemption (forexample: restrictions, escrow arrangements) Issue of ordinary shares whichrank equally with all other fullypaid ordinary shares
Date of issue/acquisition/redemption 14/8/2025

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Section 3: Authority for this announcement and contact person Section 3: Authority for this announcement and contact person Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Paul Naske
Contact person for this announcement Paul Naske
Contact phone number 021 445 154
Contact email address [email protected]
Date of release through MAP 14/8/2025